NO913712L - Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.

Info

Publication number
NO913712L
NO913712L NO91913712A NO913712A NO913712L NO 913712 L NO913712 L NO 913712L NO 91913712 A NO91913712 A NO 91913712A NO 913712 A NO913712 A NO 913712A NO 913712 L NO913712 L NO 913712L
Authority
NO
Norway
Prior art keywords
imidazole derivatives
preparation
therapeutic active
halogen
analogy procedure
Prior art date
Application number
NO91913712A
Other languages
English (en)
Norwegian (no)
Other versions
NO913712D0 (no
Inventor
Arto Johannes Karjalainen
Arja Marketta Kalapudas
Reino Olavi Pelkonen
Marja-Liisa Soedervall
Matti Antero Laehde
Risto Arvo Sakari Lammintausta
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NO913712D0 publication Critical patent/NO913712D0/no
Publication of NO913712L publication Critical patent/NO913712L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
NO91913712A 1990-09-21 1991-09-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. NO913712L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9020629A GB2248058B (en) 1990-09-21 1990-09-21 Aromatase inhibiting 4(5)-imidazoles

Publications (2)

Publication Number Publication Date
NO913712D0 NO913712D0 (no) 1991-09-20
NO913712L true NO913712L (no) 1992-03-23

Family

ID=10682560

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91913712A NO913712L (no) 1990-09-21 1991-09-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.

Country Status (20)

Country Link
EP (1) EP0476944B1 (cs)
JP (1) JPH04230668A (cs)
AT (1) ATE130295T1 (cs)
AU (1) AU640817B2 (cs)
CA (1) CA2051803A1 (cs)
CZ (1) CZ280088B6 (cs)
DE (1) DE69114644T2 (cs)
FI (1) FI914254A7 (cs)
GB (1) GB2248058B (cs)
HU (1) HUT59107A (cs)
IE (1) IE68934B1 (cs)
IL (1) IL99472A (cs)
LT (1) LT3441B (cs)
LV (1) LV10095B (cs)
NO (1) NO913712L (cs)
NZ (1) NZ239800A (cs)
PL (1) PL167741B1 (cs)
PT (1) PT99019A (cs)
RU (1) RU2036193C1 (cs)
ZA (1) ZA917476B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125924D0 (en) * 1991-06-18 1992-02-05 Orion Yhtymae Oy Stereoisomers of an imidazole derivative
GB9224144D0 (en) * 1992-11-18 1993-01-06 Erba Carlo Spa Phenyl-imidazolidinone derivatives and process for their preparation
JP2011507835A (ja) * 2007-12-21 2011-03-10 アンドレイ・アレクサンドロビッチ・イワシェンコ α−アドレナリン受容体、ドーパミン、ヒスタミン、イミダゾリン及びセロトニン受容体のリガンド並びにその使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605661A (en) * 1984-06-18 1986-08-12 Eli Lilly And Company Aromastase inhibiting α,α-diarylimidazole-4(5)-propionitriles, α,α-diarylimidazole-4(5)-propionamides, and 4(5)-(2,2-diarylethyl)imidazoles
LU85747A1 (fr) * 1985-01-28 1986-08-04 Continental Pharma Derives d'imidazole leur preparation et utilisation ainsi que les compositions pharmaceutiques contenant des derives
GB2210875B (en) * 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
GB8818561D0 (en) * 1988-08-04 1988-09-07 Ici Plc Diphenylethane derivatives
GB2231568B (en) * 1989-03-31 1992-07-08 Farmos Oy New aromatase inhibiting 4(5)-imidazoles
AU627559B2 (en) * 1989-03-30 1992-08-27 Farmos-Yhtyma Oy Novel aromatase inhibiting 4(5)-imidazoles
GB2229719B (en) * 1989-03-30 1992-04-29 Farmos Oy Novel aromatase inhibiting 4(5)-imidazoles

Also Published As

Publication number Publication date
NZ239800A (en) 1993-11-25
HUT59107A (en) 1992-04-28
IE913314A1 (en) 1992-02-25
HU913019D0 (en) 1992-01-28
AU8382691A (en) 1992-04-09
DE69114644T2 (de) 1996-05-15
FI914254A0 (fi) 1991-09-10
LT3441B (en) 1995-10-25
PT99019A (pt) 1992-08-31
GB9020629D0 (en) 1990-10-31
GB2248058A (en) 1992-03-25
GB2248058B (en) 1994-09-14
LV10095B (en) 1995-02-20
PL291747A1 (en) 1992-10-19
CS286891A3 (en) 1992-04-15
EP0476944A1 (en) 1992-03-25
JPH04230668A (ja) 1992-08-19
CA2051803A1 (en) 1992-03-22
LV10095A (lv) 1994-05-10
PL167741B1 (pl) 1995-10-31
IL99472A0 (en) 1992-08-18
EP0476944B1 (en) 1995-11-15
FI914254A7 (fi) 1992-03-22
IE68934B1 (en) 1996-07-24
ZA917476B (en) 1992-05-27
AU640817B2 (en) 1993-09-02
ATE130295T1 (de) 1995-12-15
LTIP582A (en) 1994-12-27
IL99472A (en) 1995-11-27
NO913712D0 (no) 1991-09-20
DE69114644D1 (de) 1995-12-21
RU2036193C1 (ru) 1995-05-27
CZ280088B6 (cs) 1995-10-18

Similar Documents

Publication Publication Date Title
CN1659144B (zh) 喹啉和异喹啉衍生物、其制备方法以及作为炎症抑制剂的应用
US20040116694A1 (en) Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
GB9603095D0 (en) Quinazoline derivatives
MY114679A (en) Aroyl-piperidine derivatives
DK9185A (da) Dihydropyridazinonderivater og fremgangsmaade til fremstilling deraf
NO20063330L (no) Amidderivater med en syklopropylaminokarbonylsubstituent som er nyttige som cytokininhibitorer
NO953254L (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
NO973243L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av gynekologiske sykdommer
NO934688L (no) Nye selektive aromatase-inhiberende 4(5)-imidazoler
NO995431L (no) Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse
CA2564953A1 (en) Novel indole derivatives as selective androgen receptor modulators (sarms)
NO913712L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
WO2003024976A3 (en) Tricyclic indole derivatives as 5-ht ligands
CA2528764A1 (en) Thiazoline derivatives as selective androgen receptor modulators (sarms)
DK246180A (da) Fremgangsmaade til fremstilling af paromomycinderivater
Kouznetsov et al. Transformation of schiff bases derived from alpha‐naphthaldehyde. Synthesis, spectral data and biological activity of new‐3‐aryl‐2‐(α‐naphtyl)‐4‐thiazolidinones and N‐aryl‐N‐[1‐(α‐naphthyl) but‐3‐enyl] amines
NO901451L (no) Fremgangsmaate for fremstilling av substituerte imidazolforbindelser.
Li et al. Microwave-assisted synthesis and antibacterial activity of unsymmetrical indolyl/aryl bis-thiosemicarbazones
NO993608L (no) Nye 8H-tieno-[2,3-b]pyrrolizin-8-on forbindelser, fremgangsmåte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
CA2222724A1 (en) 3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds
YU54292A (sh) Novi 4(5)-imidazoli koji selektivno inhibiraju aromatazu
HK1081193B (en) Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents